Discover Great Companies Discover Great Clients
Popularity  29.9万   |   Followers  77   |   Likes  248   |   Feedback  39 Claim this company

Manufacturing "biochips" to provide source power for the development o

No.18 Nanjing City Popularity Ranking No.4 Qixia District No.78 Jiangsu Pr No.1 Pharmaceutical CRO No.1 CRO No.1 Pharmaceutical Contracts R&D No.1 Gao Fen Zi Chemistry No.1 Zhen Duan Yong Yao No.1 He Suan Fen Zi Diagnostics No.1 Gao Fen Zi No.1 Mian Yi Xue No.1 Reagents No.1 Raw Materials No.1 Diagnostic Reagents No.2 Fen Zi Sheng Wu Xue 创新型企业 科技型中小企业 省科技型中小企业 高新技术企业 省级高新技术企业 瞪羚企业
More

Company Overview

  • Nature: Listed company Size: 1000-4999 employees Founded: 14年
  • Industry: Pharmaceuticals/Bioengineering 、 Medical devices/Equipment 、 Raw materials and processing
  • Full name: Nanjing Vazyme Biotechnology Co., Ltd.。

Development Stage

  • Stage: IPO上市, , 上交所。
  • Ranking: Ranked #18 in Nanjing City by popularity Ranked #1 in Nanjing Pharmaceutical CRO Company by popularity Ranked #1 in Nanjing CRO Company by popularity Ranked #1 in Nanjing Pharmaceutical Contracts R&D Company by popularity Ranked #1 in Nanjing Gao Fen Zi Chemistry Company by popularity
  • Honors: 2022中国新经济500强 2024中国生命科学服务100强 创新型企业 科技型中小企业 According to algorithm
  • News: 2024-04-28:盛景x诺唯赞发布「盛赞创新产业孵化培育平台」,打造生命科学领域的创新引擎。
  • Salary: 57.4% of positions earn 8-15K, In 2026 vs last yeardecreased by 3%.。Master's salary: ¥13.4K, Doctorate salary: ¥34.4K.
  • R&D: "Other (R&D and Technical)" demand: 14.2%, "Computer/Network/Technology": 9.1%, "Medical & Health/Beauty & Healthcare": 7.8%。
  • Recruiting: In 2026 vs 2025decreased by 22%. Demand for highly educated talent: Master's: 18, Doctorate: 10.
  • Requirement: Education: 本科 leads with 50.2%. Experience: 1-3年 leads with 37.1%.
  • Region: Distributed across 13 regions, 南京: 59.3%, 北京: 6.2%, 成都: 4%, 广州: 3.6%.

About the Company

[Summary] Manufacturing "biochips" to provide source power for the development o

Nanjing Vazyme Biotechnology Co., Ltd. (stock code 688105), founded in 2012 and located in the Nanjing Economic and Technological Development Zone, is a biotechnology enterprise engaged in the research and development of functional proteins such as enzymes, antigens, antibodies, and polymer organic materials, as well as product development. Relying on its independently established key common technology platforms, it has successively entered business areas such as life sciences, in vitro diagnostics, and biomedicine. It is one of the few innovative enterprises in China with both independent and controllable upstream technology development capabilities and terminal product production capabilities, committed to manufacturing "biochips" and continuously injecting new vitality into the development of the biotechnology industry.

R&D innovation capabilities and talent reserve: Vazyme has always adhered to innovation and strived for breakthroughs, insisting on starting R&D from the source of technology. Leveraging its independent core technologies, it has built independent and controllable key common technology platforms, enabling rapid, efficient, and large-scale product development. Currently, it possesses over 600 genetic engineering recombinant enzymes and over 2,500 high-performance antigens and monoclonal antibodies as key raw materials, and has more than 2,000 terminal products, which can be widely applied in scientific research, high-throughput sequencing, in vitro diagnostics, medicine and vaccine development, and animal quarantine, among other fields.

Strong R&D strength is supported by a talent team. Vazyme has an R&D innovation team of nearly 700 people, composed of interdisciplinary researchers in fields such as molecular biology, enzymology, immunology, bioinformatics, organic chemistry, and materials science, with over 67% of R&D personnel holding master's degrees or above.

Mastering core raw material technologies and aggregating downstream industry advantages: Since its inception, Vazyme has adhered to an R&D-centric business philosophy, relying on its independent core technologies, continuously upgrading and iterating technological advancements, and exploring new business areas. Through years of dedicated pursuit, Vazyme has achieved technical accomplishments in the fields of biology, healthcare, and medicine. It has successfully launched multiple series of biological reagents, including high-throughput sequencing library preparation series, PCR series, qPCR series, molecular cloning series, reverse transcription series, and Bio-assay series, as well as 9 series of POCT diagnostic reagents covering cardiovascular and cerebrovascular diseases, inflammatory infections, prenatal and postnatal care, gastric function, respiratory system, nervous system, and others, along with new drug R&D reagents. It has formed a customer base covering research institutions, high-throughput sequencing service enterprises, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals, and other medical institutions.

Upholding the mission and fulfilling responsibilities: While expanding and deepening product and technology chains, Vazyme always adheres to the mission of "fulfilling healthy life through technology," around the cycle of disease "discovery, diagnosis, prevention, and treatment," continuously developing new technologies, providing high-quality products and professional services, and creating value for customers.

Vazyme values its employees as the foundation, providing a broad development platform to attract outstanding talents from across the country and the world, promoting the overall development and enhancement of China's biomedical and medical technology industry. Vazyme actively participates in the construction of public health undertakings, using technology to support national biosecurity construction, and helping humanity overcome major infectious diseases, tumors, and autoimmune diseases!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Vazyme Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

Vazyme How Fast Is Hiring Growing? (164 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 73%
  • 2024: Up 173%
  • 2023: Down 58%
  • 2022: Down 1%
Vazyme Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Vazyme Campus Recruitment & Advanced Degree Talent Demand
Graduates 9 Interns 11 Master's 18 Doctorate 10
Note: How fast is hiring at Nanjing Vazyme Biotechnology Co., Ltd. growing? Vazyme2026: 429 openings (down 22%), 2025: 553 openings (up 73%), 2024: 319 openings (up 173%), 2023: 117 openings (down 58%), 2022: 276 openings (down 1%), 2021: 279 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Vazyme Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 4%
  • 2024: Up 90%
  • 2023: Down 53%
  • 2022: Up 42%
Vazyme Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Nanjing Vazyme Biotechnology Co., Ltd. growing? VazymeMaster's recruitment over the years: 2025: 55 openings (down 4%), 2024: 57 openings (up 90%), 2023: 30 openings (down 53%), 2022: 64 openings (up 42%), 2021: 45 openings. Vazyme master talent ranking in Nanjing: #50, Vazyme master salary mostly around 8-15K.

Vazyme Doctoral Degree Job Demand Analysis

(More)
-52%
Growth Rate
2026 vs 2025
  • 2025: Down 8%
  • 2024: Up 300%
  • 2023: Down 31%
  • 2022: Up 550%
Vazyme Doctoral Hiring by Year: 2026 — 17 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Nanjing Vazyme Biotechnology Co., Ltd. growing? VazymeDoctorate recruitment over the years: 2026: 16 openings (down 52%), 2025: 33 openings (down 8%), 2024: 36 openings (up 300%), 2023: 9 openings (down 31%), 2022: 13 openings (up 550%), 2021: 2 openings. Vazyme doctorate talent ranking in Nanjing: #14, Vazyme doctorate salary mostly around 20-50K.

Vazyme R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Nanjing Vazyme Biotechnology Co., Ltd.? Based on an analysis of Vazyme's job postings over the past year, "Other (R&D and Technical)" demand: 14.2%, "Computer/Network/Technology": 9.1%, "Medical & Health/Beauty & Healthcare": 7.8%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 6.9%, "Mechanical/Instrumentation": 3.5%, "Agriculture, Forestry and Fishery": 2.2%. For reference only.

Vazyme — What Are the Salaries Like? (549 records)

Manage
salary range: 3K - 50K, 57.4% of roles pay ¥8-15K
Note: salary statistics are based on 549 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Nanjing Vazyme Biotechnology Co., Ltd.?Vazyme57.4% of positions earn 8-15K, Fresh graduate salary: ¥24.0K。Nanjing salary ranking top 30,销售类 average salary ¥18.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Vazyme

(More)
Are salaries high at Nanjing Vazyme Biotechnology Co., Ltd.? We provide: Sales, After-sales Service, BP, Intern, HR, 临床, Product Manager, Application Engineer, R&D Engineer, Product Specialist, Channel Manager, Finance Specialist, Analyst, Marketing, Administrative Specialist, Quality, Project Manager, Key Account, International Business Specialist, Management Trainee. Click to view detailed salary analysis by job.

Vazyme — Fortune 500? (More)

Yes, ranked in 中国新经济500强:

  • NO.248 2022中国新经济500强 >

Yes, ranked in 中国生命科学服务100强:

  • NO.26 2024中国生命科学服务100强 >
  • NO.46 2023中国生命科学服务100强 >
  • NO.72 2022中国生命科学服务100强 >

Job Category

  • 销售类
    30.2% of total 30.2%
  • 其他(研发和技术类)
    14.2% of total 14.2%
  • 经营管理类
    12.7% of total 12.7%
  • 在校学生类
    12.5% of total 12.5%

Education

  • 本科
    50.2% of total 50.2%
  • 大专
    25.6% of total 25.6%
  • 硕士
    13.3% of total 13.3%
  • 不限
    6.9% of total 6.9%

Experience

  • 1-3年
    37.1% of total 37.1%
  • 不限
    29.8% of total 29.8%
  • 5-10年
    15.1% of total 15.1%
  • 3-5年
    14.7% of total 14.7%
View Detailed Analysis

What does Nanjing Vazyme Biotechnology Co., Ltd. require? Who is Vazyme hiring? Vazyme recruitment: 销售类占比最多占30.2%,其次是其他(研发和技术类)占14.2%. What education can get in at Vazyme? 本科占比最多占50.2%,其次是大专占25.6%. High education required at Vazyme? 硕士占13.3%,博士占3.6%. Work experience required at Vazyme? 1-3年占比最多占37.1%,其次是不限占29.8%. Where are the job locations at Vazyme? 南京占比最多占59.3%,其次是北京占6.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 39,773.4544万(元)
Legal Representative: 曹林
Date Established:
Credit Code: 91320192589435065R
Registered Address: 南京经济技术开发区科创路红枫科技园C1-2栋东段1-6层

Partners & Suppliers

为本素药业提供研发用生物试剂及耗材 Source
合作客户 试剂与耗材
仁度生物向其采购分子诊断所需的酶类等生物试剂原料 Source
合作客户 诊断试剂酶与抗原抗体原料
供应诊断试剂所用的酶及抗体原料 Source
合作客户 生物原料
南京诺唯赞生物科技股份有限公司向南通井兰生物技术有限公司提供生物酶等原料,用于诊断试剂生产。 Source
合作客户 生物试剂原料
向圣庭医学提供分子诊断原料及试剂 Source
合作客户 检验耗材

People who follow Vazyme also follow

Vazyme Competitors (Similar Companies)

生物科技/生物工程 医药 基因合成 生物医药
“Health for Humanity, Creating a Better Future Together”
“Helping patients access more effective medicines sooner”
创业孵化 创业投资 企业孵化 创新服务
“It is an innovation-driven pharmaceutical group integrating drug resea”
通信工程监理 造价咨询 工程监理 通信工程
软膏剂 医药工业 原料药 制药/药业
产业互联网 数字化服务 定制 社群运营
“让工业更智能”
速冻食品 火锅料制品 生产 火锅
耐火 矿用电缆 控制电缆 钢芯铝绞线
企业管理 企业服务 人才服务 项目申报
“Research, development, and production of anti-tumor and surgical medic”
金融 卡圈 企业信用 银行
物联网/IoT 智能安全 智能制造/生产/加工 智慧工厂

Discover Great Companies, Discover Great Clients

南京公司名录 南京“Qixia District”公司名录 南京“分子生物学”公司名录 南京“生物科技/生物工程”公司名录 南京“生命科学研究”公司名录 南京“抗体”公司名录 南京“诊断试剂”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates